Amikacin Dosing for a 1-Year-Old Child
For a 1-year-old child with normal renal function, administer amikacin 15-22.5 mg/kg/day divided every 8 hours (5-7.5 mg/kg every 8 hours), or alternatively 15-20 mg/kg once daily as a single dose. 1, 2
Standard Dosing Regimen
Divided Dosing (Traditional Approach)
- Administer 5-7.5 mg/kg every 8 hours (total daily dose 15-22.5 mg/kg/day) 1, 2
- For a typical 1-year-old weighing 10 kg, this translates to 50-75 mg every 8 hours 1
- This is the FDA-approved dosing regimen for infants and children 3
Once-Daily Dosing (Alternative Approach)
- Administer 15-20 mg/kg as a single daily dose 2, 3
- For a 10 kg child, this would be 150-200 mg once daily 2
- Once-daily dosing has demonstrated superior clinical cure rates (83% vs 66%) and reduced nephrotoxicity (21% vs 35%) compared to twice-daily dosing in pediatric patients 4, 5
Critical Dosing Considerations
Route of Administration
- Intravenous infusion over 30-60 minutes is preferred for hospitalized patients 3
- For infants specifically, extend the infusion time to 1-2 hours 3
- Intramuscular administration at 15 mg/kg once daily is effective for outpatient treatment of uncomplicated infections 6
Special Clinical Situations
- For severe infections or febrile neutropenia: Consider initial doses up to 30 mg/kg/day divided every 8 hours if serum levels document the need 1, 2
- For cystic fibrosis patients: Higher doses (up to 30 mg/kg/day) may be required due to altered pharmacokinetics 1
Therapeutic Drug Monitoring
Target Levels
- Peak concentration: 30-40 mg/L for once-daily dosing 2, 7
- Trough concentration: <5 mg/L to prevent toxicity 8, 9
- Measure peak levels 30-90 minutes after infusion completion 2
- Measure trough levels immediately before the next dose 2
Monitoring Schedule
- Obtain baseline serum creatinine before initiating therapy 8
- Check amikacin levels within the first week of therapy 8, 7
- Monitor renal function monthly during treatment 1, 8
Safety Monitoring and Toxicity Prevention
Baseline Assessment
- Obtain baseline audiogram if prolonged therapy (>10 days) is anticipated 8
- Document baseline renal function (serum creatinine) 8, 3
Ongoing Monitoring
- Nephrotoxicity risk: Occurs in 8.7% overall, but only 3.4% in patients without risk factors 8
- Ototoxicity risk: Ranges from 1.5-24% depending on treatment duration and cumulative dose 8
- Question parents about auditory symptoms (hearing loss, tinnitus) or vestibular symptoms (dizziness, balance problems) at each visit 1, 8
Duration of Therapy
- Limit treatment to 7-10 days whenever feasible 3
- If treatment beyond 10 days is necessary, reassess the indication and intensify monitoring for toxicity 3
- The total daily dose should not exceed 15 mg/kg/day by all routes combined 3
Common Pitfalls to Avoid
Dosing Errors
- Never use fixed 500 mg doses regardless of weight—this ignores body weight entirely and risks treatment failure in children 8, 2
- Do not reduce the milligram dose in renal impairment—instead, extend the dosing interval while maintaining the same mg/kg dose 8
- Avoid underdosing: Ensure peak concentrations reach 30-40 mg/L, as subtherapeutic levels lead to treatment failure 7
Pharmacokinetic Variability
- Children demonstrate wide interpatient variability in amikacin pharmacokinetics, with volume of distribution varying by a factor of 6 and elimination half-life by a factor of 10 5
- Initial serum monitoring is essential due to this variability 7
- A loading dose of 20 mg/kg may be necessary to achieve therapeutic peak concentrations between 30-40 mg/L 7